New cord blood transplant shows promise for tough leukemia cases
NCT ID NCT03913026
First seen Nov 01, 2025 · Last updated Jun 05, 2026 · Updated 31 times
Summary
This study tests a new way to use cord blood transplants for people with high-risk leukemia or myelodysplasia. The approach expands cord blood stem cells with a molecule called UM171 to improve recovery and reduce complications. About 30 participants will receive this transplant to see if it lowers transplant-related deaths and improves survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemont
Montreal, Quebec, H1T2M4, Canada
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.